Black Diamond Therapeutics, Inc. (BDTX) Tops Q1 EPS by 3c
Tweet
Share
E-mailGet Alerts BDTX Hot Sheet
Join SI Premium – FREE
Black Diamond Therapeutics, Inc. (NASDAQ: BDTX) reported Q1 EPS of ($0.16), $0.03 better than the analyst estimate of ($0.19).
For earnings history and earnings-related data on Black Diamond Therapeutics, Inc. (BDTX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- UBS Starts Kalyan Jewellers India Ltd (KALYANKJ:IN) at Buy
- BetterLife Pharma files final prospectus for $100M public offering
- Ivonescimab cuts death risk 27% vs. pembrolizumab in lung cancer
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
